NASDAQ:LPCN

Lipocine Stock Insider Trading

etoro logo Buy LPCN
*Your capital is at risk
$2.12
+0.0100 (+0.474%)
At Close: Jul 31, 2026

Lipocine Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.24M and sold 0 LPCN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 3.24M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Nov 01, 2022
Buy
Common Stock
J-Other
Nomikos George
Insider
Unknown 0
Value: $0
Nov 01, 2022
Buy
Stock Option (Right to Buy)
A-Award
Nomikos George
Chief Medical Officer
Officer 125 000
Value: $50.8K
Sep 27, 2022
Buy
Common Stock
P-Purchase
Patel Mahesh V.
CEO And President
CEO / President 100 000
Value: $41.0K
Sep 27, 2022
Buy
Common Stock
P-Purchase
Patel Mahesh V.
CEO And President
CEO / President 100 000
Value: $41.0K
Jun 08, 2022
Buy
Common Stock (Right to Buy)
A-Award
Ono Richard Dana
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Common Stock (Right to Buy)
A-Award
Higuchi John W.
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Stock Option (Right to Buy)
A-Award
Papapetropoulos Spyros
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Common Stock (Right to Buy)
A-Award
Fink Jeffrey Arvin
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Stock Option (Right to Buy)
A-Award
Jene Jill M.
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Stock Option (Right to Buy)
A-Award
Jene Jill M.
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Common Stock (Right to Buy)
A-Award
Fink Jeffrey Arvin
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Stock Option (Right to Buy)
A-Award
Papapetropoulos Spyros
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Common Stock (Right to Buy)
A-Award
Higuchi John W.
Director 22 000
Value: $20.2K
Jun 08, 2022
Buy
Common Stock (Right to Buy)
A-Award
Ono Richard Dana
Director 22 000
Value: $20.2K
May 17, 2022
Buy
Common Stock
P-Purchase
Fogarty Krista
Principal Accounting Officer
Officer 12 500
Value: $10.8K
May 17, 2022
Buy
Common Stock
P-Purchase
Fogarty Krista
Principal Accounting Officer
Officer 12 500
Value: $10.8K
May 16, 2022
Buy
Common Stock
P-Purchase
Patel Mahesh V.
CEO And President
CEO / President 50 000
Value: $38.5K
May 16, 2022
Buy
Common Stock
P-Purchase
Patel Mahesh V.
CEO And President
CEO / President 50 000
Value: $38.5K
Apr 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Papapetropoulos Spyros
Director 10 000
Value: $11.6K
Apr 11, 2022
Buy
Common Stock
J-Other
Papapetropoulos Spyros
Director 0
Value: $0
Apr 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Jene Jill M.
Director 10 000
Value: $11.6K
Apr 11, 2022
Buy
Common Stock
J-Other
Jene Jill M.
Director 0
Value: $0
Apr 11, 2022
Buy
Common Stock
J-Other
Jene Jill M.
Director 0
Value: $0
Apr 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Jene Jill M.
Director 10 000
Value: $11.6K
Apr 11, 2022
Buy
Common Stock
J-Other
Papapetropoulos Spyros
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LIPOCINE INC.
Lipocine
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE